Author： Paggiaro P.L. Bacci E. Dente F.L. Di Franco A. Giannini D. Vagaggini B.
Publisher： Academic Press
ISSN： 1094-5539
Source： Pulmonary Pharmacology & Therapeutics, Vol.11, Iss.5, 1998-10, pp. : 401-405
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Phosphodiesterase 4 Inhibitors for the Treatment of Asthma and COPD
Current Medicinal Chemistry, Vol. 13, Iss. 27, 2006-11 ,pp. :
Blood Eosinophils as Biomarkers to Drive Treatment Choices in Asthma and COPD
Current Drug Targets, Vol. 19, Iss. 16, 2018-12 ,pp. :
Inpharma, Vol. 1, Iss. 1318, 2001-01 ,pp. :
Roflumilast promising in COPD and asthma
Inpharma, Vol. 1, Iss. 1364, 2002-01 ,pp. :